PIN Pharma to Present at Life Sciences Summit 2016

NEW YORK–(BUSINESS WIRE)– PIN Pharma, a pre-IND immunotherapy company focused on modulating the
immune system in oncology, today announced it will be presenting at the
Life Sciences Summit 2016 on Thursday, November 3rd at 4 pm in the 10 on
the Park Tower Room of the Time Warner Center in New York City.

About PIN Pharma, Inc.

PIN Pharma is a pre-IND stage venture backed immunotherapy company
focused on the development of PINS (precision immune stimulants). The
lead compound PIN-2 is a first-in-class, novel, next-generation
engineered peptide that empowers the immune system in vivo. The
Company’s technology primes the innate immune system to modulate
adaptive immunity thereby generating and expanding antigen-specific
cytotoxic T-cells in vivo. The company is advancing PIN-2 to the clinic
early first quarter 2017.

Contact

For more information about PIN Pharma and PIN-2, contact Mark Smith, CBO
(msmith@pinpharma.com) or
Colin Bier, CEO (cbier@pinpharma.com)
at PIN Pharma, Inc., 3960 Broadway, Suite 620, New York, NY, or call
212-543-2583.

Image may be NSFW.
Clik here to view.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161031005620/en/